Business Description
Valerio Therapeutics is a Paris-based clinical-stage biotech company focused on developing advanced platforms for delivering targeted medical treatments. Its core work centers on three proprietary technologies designed to fight disease at a molecular level, including a chemical platform for DNA-based therapies, a protein degradation mechanism, and an antibody-based system for engaging the immune system against cancer. Originally founded in 1997 under the name Onxeo SA, the company rebranded to Valerio Therapeutics in June 2023.
